STEMPOINT CAPITAL LP

Position in BIOA — BioAge Labs, Inc.

CIK 1952142 NEW YORK, NY

Position in BIOA

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$5,923,058

New position

Shares Held

338,654

first reported quarter

Ownership

0.762%

of shares outstanding

% of Portfolio

1.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 90.76431992535154.ToString("F0")% Shared 0.ToString("F0")% None 9.235680074648462.ToString("F0")%

Healthcare · as of Mar 31, 2026

STEMPOINT CAPITAL LP holds $18,077,876 across 3 Drug Manufacturers - Specialty & Generic names. BIOA ranks #2 (32.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMLX	Amylyx Pharmaceuticals, Inc.	669,685	$9,308,621
2	BIOA	BioAge Labs, Inc. This page	338,654	$5,923,058
3	ALKS	Alkermes plc.	80,492	$2,846,197

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,923,058	338,654	—	Shares	Sole	2026-05-18
No filing history on record for this holder in this stock.